LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,951,143 | +105.3% | 356,575 | +111.0% | 0.01% | +100.0% |
| Q2 2023 | $11,668,071 | +41.1% | 169,029 | -1.4% | 0.00% | +33.3% |
| Q1 2023 | $8,268,091 | +50.5% | 171,466 | +55.8% | 0.00% | +50.0% |
| Q4 2022 | $5,494,046 | +37.0% | 110,057 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $4,010,000 | -17.6% | 98,291 | +11.0% | 0.00% | 0.0% |
| Q2 2022 | $4,869,000 | +31.9% | 88,530 | -12.9% | 0.00% | +100.0% |
| Q1 2022 | $3,692,000 | -22.6% | 101,595 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $4,773,000 | +66.7% | 102,404 | +80.7% | 0.00% | 0.0% |
| Q3 2021 | $2,864,000 | +2946.8% | 56,656 | +2374.1% | 0.00% | – |
| Q2 2021 | $94,000 | +74.1% | 2,290 | +23.3% | 0.00% | – |
| Q1 2021 | $54,000 | -1.8% | 1,857 | -5.7% | 0.00% | – |
| Q4 2020 | $55,000 | +52.8% | 1,970 | +68.7% | 0.00% | – |
| Q3 2020 | $36,000 | +71.4% | 1,168 | +133.6% | 0.00% | – |
| Q2 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |